Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Oral Ketamine as an Adjuvant to Opioids for Pain Treatment in Cancer Patients


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01207206

Organisation Name: Tel-Aviv Sourasky Medical Center

Overal Status: Unknown status

Start Date: October 2010

Last Update: November 1, 2011

Lead Sponsor: Tel-Aviv Sourasky Medical Center

Brief Summary: In the current research the investigators would like to examine the effect of a well acquainted drug, Ketamine, which is used by anesthesiologists to induce sleep in operations. Usually the ketamine is given into the vein and not orally. The investigators want to give it orally to cancer patients that sufffer from severe pain to find out whether it can prove their quality of life, lower their pain and reduce the amount of opioids they receive.

Conditions:
  • Cancer
  • Pain
  • Tolerance


Total execution time in seconds: 0.23442101478577